神經障礙治療領域的開發平台 是由出版商Life Science Analytics在2011年03月所出版的。
這份英文市場調查報告書包含Pages: 274 價格從美金1495起跳。
本報告提供神經障礙治療領域的開發平台趨勢分析，不同企業，各治療階段的趨勢，開發最新資訊等資料，為您概述為以下內容。
產品的比例(各開發階段)
產品數(各開發階段)
上市產品和開發平台產品
企業概要:開發平台計劃
- 說明
- 早期階段的神經障礙治療藥物的前五名公司
- 後期階段的神經障礙治療藥物的前五名公司
- 已上市神經障礙治療藥物的前五名公司
專利的失效
下一個里程碑
產品銷售額
開發平台的全貌
- 產品概要:不明·研究階段
- 產品概要:前臨床階段
- 產品概要:第一期臨床試驗
- 產品概要:第二期臨床試驗
- 產品概要:第三期臨床試驗
- 產品概要:認可完畢
- 產品概要:上市後
最新趨勢
Abstract
Life Science Analytics' , Neuropathy Therapy Area Pipeline Report contains
detailed information on the allergy drug pipeline. This report provides
insight into the pipeline status of neuropathy drugs by company and by stage
as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Life Science Analytics’ Therapy Area Pipeline Report provides the
user with real detail on drug pipelines, by company and by stage, for each
specific therapy area. The latest news, by company, also ensures that each
report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each
report also contains extensive information in tabular format on a
company’s full product pipeline and products by phase of development
with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product
descriptions, information on partnering activity plus clinical trial
intelligence. Each Therapy Area Pipeline Report also provides detail on the
top 20 companies with products in the early stage of development and the top
20 companies with products in the late stage of development. Finally, each
report also provides a comparison with other major indications in the disease
hub based on Marketed Products vs. Pipeline Products.
Key benefits
* Understand a company’s strategic position by accessing detailed
independent intelligence on its product pipeline for specific therapy
areas.
* Keep track of your competitors and partners by better
understanding their product pipeline.
* Monitor a company’s
research effectiveness by determining pipeline depth and number of products in
development by clinical phase for specific disease areas.
* Maintain
a critical competitive advantage.
Table of Contents
% of Products by Phase of Development
No. of Products by Phase of
Development
Marketed Products vs. Pipeline Products
Company Overview -
Pipeline Projects
Legend
--Top 5 Companies in Early Stage
Neuropathy Products
--Top 5 Companies in Late Stage Neuropathy
Products
--Top 5 Companies in Marketed Neuropathy Products
Patent
Expirations
Upcoming Milestones
Product Sales
Full Pipeline
View
--Product Details : Unknown/Research
--Product Details : Pre
Clinical
--Product Details : Phase I
--Product Details : Phase II
--Product Details : Phase III
--Product Details : Approved
--Product
Details : On the Market
News Updates
--Deals & Alliances
--Product
Updates
--Regulatory
